The new cleanroom at our global headquarters in Salt Lake City, Utah, was designed for today's rigorous contamination control expectations, driven by EU GMP Annex 1. Learn More
To consistently deliver safe and effective pharmaceutical products, processes for impurity control must be established and followed. It is both unfortunate and inconvenient to encounter an unexpected impurity while practicing routine quality control. It requires immediate action to identify, quantify,...
When a medicinal product (drug or biologic) meets a medical device, a combined product is created. Incompatibility between the components can present a danger to the patient, but how can one demonstrate the fit between a medicinal product and a...
